IWC
CAPR icon

Integrated Wealth Concepts’s Capricor Therapeutics CAPR Stock Holding History

Integrated Wealth Concepts’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.2K Buy
+756
New +$22.9K ﹤0.01% 4160

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Integrated Wealth Concepts's CAPR Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Capricor Therapeutics (CAPR) in Q2 2026: 756 shares worth $18.2K. The stake represents ﹤0.01% of the portfolio and ranks #4160 among its holdings.

170 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Integrated Wealth Concepts held 756 shares of Capricor Therapeutics worth $18.2K as of Q2 2026.
  • Capricor Therapeutics was a new Integrated Wealth Concepts position in Q2 2026.
  • Capricor Therapeutics made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #4160 holding.
  • 170 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.